WASHINGTON (Reuters) – The U.S. House Oversight and Reform Committee has questioned four companies over their plans to use a tax provision passed in a COVID-19-related law to address their litigation costs tied to their role in the nation’s opioid crisis, it said in a statement on Friday.
The panel sent letters to Cardinal Health, McKesson Corporation, AmerisourceBergen, and Johnson & Johnson seeking further related information, the statement said.
(Reporting by Susan Heavey)
Shai Gilgeous-Alexander’s 33 points lead Thunder past Pelicans 124-92 as OKC takes a 2-0 lead
Bruins beat Maple Leafs 4-2 in Game 3 to take series lead
Herro scores 24, Heat hit franchise playoff-record 23 3s to beat Boston and even series 1-1
Shohei Ohtani has 3 doubles, Landon Knack gets 1st victory as Dodgers rout Nationals 11-2
Cubs reliever Luke Little forced to change his glove because of white in American flag patch
US coalition warship shoots down missile fired by Yemen’s Houthi rebels over the Gulf of Aden
A look at the Gaza war protests that have emerged on US college campuses
Blinken raises Chinese trade practices in meetings with officials in the financial hub of Shanghai
A high-profile murder trial in Kazakhstan boosts awareness of domestic violence
Venice launches experiment to charge day-trippers an access fee in bid to combat over-tourism
Top women honored at Schneps Media Power Women of Manhattan
City Council approves zoning changes to legalize casinos in the Big Apple
Cannabis 101: Confused by New York’s marijuana laws? Here’s what you need to know ahead of 4/20
Samuel Waxman Cancer Research Foundation brings New York power-brokers together for fundraiser
